Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial

Fig. 1

Study flow with patients enrolled, randomized and analyzed for primary endpoint. SC: Standard of Care therapy (control arm). SP: Standard Plasma (experimental arm). CCP: Covid-19 Convalescent Plasma (experimental arm). *The patient withdrew the consent the day after randomization before starting treatment. **Four patients died after second SP infusion. ***2 patients died after first and 2 after second CCP infusion, 1 patient withdrew the consent after second infusion because of a moderate allergic reaction

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us